Quantcast

Latest Antibiotic-resistant bacteria Stories

2014-04-30 12:30:48

DUBLIN, Apr. 30, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/9drj5b/hospital_acquired) has announced the addition of the "Hospital Acquired Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 This report covers the market analysis for various diagnostic tests performed to detect hospital associated infections, also...

2014-04-30 08:32:05

FIRST® - Vancomycin compounding kits make pharmacy compounding easier WOBURN, Mass., April 30, 2014 /PRNewswire/ -- CutisPharma, Inc. announced the introduction of FIRST(® )- Vancomycin oral solution compounding kits. With FIRST(®) - Vancomycin, the oral solution is compounded within a minute by adding the pre-measured white grape flavored solution to the pre-weighed vancomycin hydrochloride powder bottle and shaking it. The pleasant white grape flavor helps mask the typical...

2014-04-29 20:27:04

LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment)http://www.reportbuyer.com/pharma_healthcare/healthcare/market_hospital_acquired_infection_control_sterilization_disinfection_testing_treatment.html Given the cost of hospital-acquired and healthcare-associated infections (HAIs), demand has increased for solutions that can help the...

Nanosponge Disguise Fights Superbug Infections
2014-04-28 03:12:11

[ Watch The Video: Nanosponge Decoy Fights Superbug Infections ] National Science Foundation A good disguise enables the nanosponge to soak up toxins from drug-resistant infections or poisons Our first instinct with infection in the body is often to find it and get rid of it! But, engineer Liangfang Zhang had another idea. With support from the National Science Foundation (NSF), Zhang and his team at the University of California, San Diego (UCSD), have created a nanosponge to...

2014-04-25 08:24:28

DUBLIN, April 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/9r9mx8/enteric_disease) has announced the addition of the "Enteric Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" [http://www.researchandmarkets.com/research/9r9mx8/enteric_disease ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Enteric diseases are...

2014-04-16 23:06:57

Officials at Clearstream, LLC, who previously spoke out about MRSA’s prevalence in athletic facilities, are now warning of the infection’s spread to communities. In order to prevent what is now a growing public health threat, Clearstream is advancing the first antimicrobial technology that actively provides long-term protection without the use of harmful poisons. Harrisburg, NC (PRWEB) April 16, 2014 Historically, MRSA infections were relegated to sick patients in hospitals and...

2014-04-08 12:31:11

WOBURN, Mass. and VEDBAEK, Denmark, April 8, 2014 /PRNewswire/ -- AdvanDx, Inc. today announced it has closed a $12 million financing led by Merck Global Health Innovation Fund (Merck GHI) with participation from existing investors SLS Ventures AB and LD Pensions. The Series B-1 financing will be used to fund the expansion of AdvanDx's molecular diagnostic product offerings, as well as its sales and marketing presence in the U.S. and internationally. "We continue to see increased...

2014-04-08 08:29:54

IRVINE, Calif., April 8, 2014 /PRNewswire/ -- Sideromics LLC, a pharmaceutical company specializing in the development of novel antimicrobial compounds, announced today that the company has successfully completed a Type B pre-investigational new drug (PIND) meeting with the U.S. Food and Drug Administration (FDA) Division of Anti-Infective Products (DAIP). The purpose of the meeting was to obtain FDA concurrence on the nonclinical, clinical, and regulatory pathway for the development of...

2014-04-01 08:29:55

CHICAGO, April 1, 2014 /PRNewswire-USNewswire/ -- "Get tested", says MRSA Survivors Network's founder and national spokesperson Jeanine Thomas. "It could save your life". Healthcare-acquired infections, community-acquired MRSA methicillin-resistant staphyloccocus aureus (CA-MRSA) and antimicrobial resistance- (AMR) are a major global health threat and crisis. Every single day in the United States >200 patients die from a preventable healthcare-acquired infection. Patients...

2014-03-31 08:28:42

-- Conference Call Today, March 31, 2014, at 10:00 a.m. (EDT) -- ROCKVILLE, Md., March 31, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and other diseases, today reported financial results for the year ended December 31, 2013 and provided operational highlights. http://photos.prnewswire.com/prnvar/20130522/MM19465LOGO Recent Operational Highlights...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related